vimarsana.com

Latest Breaking News On - Dose inhalers - Page 1 : vimarsana.com

Sunshine Holdings' healthcare arm woos IFC to take up 14.7% stake for Rs. 3.27 b

Sunshine Holdings' healthcare arm woos IFC to take up 14.7% stake for Rs. 3.27 b
ft.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ft.lk Daily Mail and Mail on Sunday newspapers.

Maldives
Sri-lanka
Sri-lankans
Asia-pacific-riccardo-puliti
Asia-imad-fakhoury
Victor-antonypillai
Shyam-sathasivam
Hiran-samarasinghe
Pacific-riccardo-puliti
Aruna-deepthikumara
Priyanka-cooray
Sunshine-holding

IFC Set to Invest Up to LKR 3,270 million in Sunshine Healthcare Lanka Limited - Adaderana Biz English

IFC Set to Invest Up to LKR 3,270 million in Sunshine Healthcare Lanka Limited - Adaderana Biz English
bizenglish.adaderana.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizenglish.adaderana.lk Daily Mail and Mail on Sunday newspapers.

Sri-lanka
Sri-lankans
Shyam-sathasivam
Roshani-kobbekaduwa
Aruna-deepthikumara
Riccardo-puliti
Hiran-samarasinghe
Group-legal
Sunshine-holdings
Pharmaceuticals-distribution
Sunshine-holding
International-finance-corporation

IFC to invest Rs.3,270Mn in Sunshine Healthcare Lanka Ltd

IFC to invest Rs.3,270Mn in Sunshine Healthcare Lanka Ltd
lankabusinessonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lankabusinessonline.com Daily Mail and Mail on Sunday newspapers.

Sri-lanka
Sri-lankans
Hiran-samarasinghe
Aruna-deepthikumara
Riccardo-puliti
Roshani-kobbekaduwa
Shyam-sathasivam
Sunshine-holding
Pharmaceuticals-distribution
Group-legal
International-finance-corporation
Sunshine-holdings

Respiratory Drug Delivery Market Report 2024-2034

Pulmonary Drug Delivery Devices Market to Exceed Value of USD 49.5 Billion by 2031, TMR Study

The rise in the prevalence of major respiratory disorders is expected to drive the pulmonary drug delivery devices market during the forecast period.Wilmington, Delaware, United States, Nov. 23, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. -The global pulmonary drug delivery devices market is projected to flourish at a CAGR of 4.7% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 49.5 billion is anticipated for the market in 2031. As of 2023, the demand for

United-states
Canada
Delaware
America
Nikhil-sawlani
Boehringer-ingelheim-gmb
Asia-pacific
Chiesi-farmaceutici
Koninklijke-philips
Teva-pharmaceutical-industries-ltd
Ask-expert-for-the-research
Glaxosmithkline

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.